Sol-Gel Technologies (SLGL) Return on Capital Employed Growth (5y) (2023 - 2026)
Sol-Gel Technologies (SLGL) Return on Capital Employed Growth (5y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,184.45 Bn | 68,184.17 Bn | - |
| 2 | Nanobiotix | 1,953.19 Bn | 1,953.13 Bn | - |
| 3 | Akari Therapeutics | 1,132.35 Bn | 1,132.35 Bn | - |
| 4 | BeOne Medicines | 474.39 Bn | 469.59 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 123.45 Bn | 116.21 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.92 Bn | 61.16 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.43 Bn | 63.43 Bn | - |
| 8 | Argenx Se | 56.67 Bn | 51.49 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 38.08 Bn | 38.08 Bn | - |
| 10 | Sol-Gel Technologies | 241.68 Mn | 231.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,129.00 |
| Dec 31, 2025 | 4,183.00 |
| Sep 30, 2025 | 8,724.00 |
| Jun 30, 2025 | 8,019.00 |
| Mar 31, 2025 | 5,433.00 |
| Dec 31, 2024 | 4,880.00 |
| Sep 30, 2024 | -4,845.00 |
| Jun 30, 2024 | -6,415.00 |
| Mar 31, 2024 | -8,625.00 |
| Dec 31, 2023 | -6,438.00 |
| Sep 30, 2023 | -5,075.00 |